Effects of the adenosine A2A receptor antagonist KW6002 on the dopaminergic system, motor performance, and neuroinflammation in a rat model of Parkinson's disease
Open Access
- 5 February 2024
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 247, 109862
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Functional interaction between pre‐synaptic α6β2‐containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatumBritish Journal of Pharmacology, 2013
- Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microgliaJournal of Neuroinflammation, 2013
- Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic PainMediators of Inflammation, 2013
- Modulation of Striatal Projection Systems by DopamineAnnual Review of Neuroscience, 2011
- Dopamine in Motivational Control: Rewarding, Aversive, and AlertingNeuron, 2010
- Fully automated synthesis and initial PET evaluation of [11C]PBR28Bioorganic & Medicinal Chemistry Letters, 2009
- GDNF control of the glutamatergic cortico‐striatal pathway requires tonic activation of adenosine A2AreceptorsJournal of Neurochemistry, 2009
- Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathwayJournal of Neuroinflammation, 2008
- Partial-Volume Effect in PET Tumor ImagingJournal of Nuclear Medicine, 2007
- Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA modelJournal of Neuroscience Methods, 2006